BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24999677)

  • 1. Tumor thrombus: ancillary findings on FDG PET/CT in an oncologic population.
    Ravina M; Hess S; Chauhan MS; Jacob MJ; Alavi A
    Clin Nucl Med; 2014 Sep; 39(9):767-71. PubMed ID: 24999677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidental diagnosis of tumor thrombosis on FDG PET/CT imaging.
    Erhamamci S; Reyhan M; Nursal GN; Torun N; Yapar AF
    Rev Esp Med Nucl Imagen Mol; 2015; 34(5):287-94. PubMed ID: 26025479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG PET-CT in the diagnosis of tumor thrombus: can it be differentiated from benign thrombus?
    Sharma P; Kumar R; Jeph S; Karunanithi S; Naswa N; Gupta A; Malhotra A
    Nucl Med Commun; 2011 Sep; 32(9):782-8. PubMed ID: 21799368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of 18 F-FDG PET/CT in the diagnosis of benign vs. malignant tumor thrombus.
    Sarswat S; Khan D; Sagar S; Kumar R
    Nucl Med Commun; 2023 Aug; 44(8):726-731. PubMed ID: 37272295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging thrombus in cancer patients with FDG PET-CT.
    Sharma P; Kumar R; Singh H; Jeph S; Patnecha M; Reddy RM; Naswa N; Bal C; Malhotra A
    Jpn J Radiol; 2012 Feb; 30(2):95-104. PubMed ID: 22205138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of
    Wu B; Zhang Y; Tan H; Shi H
    Abdom Radiol (NY); 2019 Jul; 44(7):2430-2435. PubMed ID: 30944961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of 18F-FDG PET/CT in differentiating malignant from benign portal vein thrombosis.
    Hu S; Zhang J; Cheng C; Liu Q; Sun G; Zuo C
    Abdom Imaging; 2014 Dec; 39(6):1221-7. PubMed ID: 24913670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG PET/CT Findings in Portal Vein Thrombosis and Liver Metastases.
    Surasi DS; O'Malley JP; Bhambhvani P
    J Nucl Med Technol; 2015 Sep; 43(3):229-30. PubMed ID: 25655342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma.
    Sun L; Guan YS; Pan WM; Chen GB; Luo ZM; Wei JH; Wu H
    World J Gastroenterol; 2008 Feb; 14(8):1212-7. PubMed ID: 18300346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ¹⁸F-FDG PET CT as an independent prognostic indicator in patients with hepatocellular carcinoma.
    Pant V; Sen IB; Soin AS
    Nucl Med Commun; 2013 Aug; 34(8):749-57. PubMed ID: 23689586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Color Doppler imaging of inferior vena cava: identification of tumor thrombus.
    Hübsch P; Schurawitzki H; Susani M; Theyer G; Traindl O; Pölzleitner D; Trattnig S; Metz V
    J Ultrasound Med; 1992 Dec; 11(12):639-45. PubMed ID: 1337360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of Malignant Thrombus From Bland Thrombus of the Portal Vein in Patient With Hepatocellular Carcinoma on 18F-FDG PET CT.
    Agarwal KK; Shah D; Shah N; Mayank M
    Clin Nucl Med; 2017 Nov; 42(11):e472-e474. PubMed ID: 28922192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of [(18)F]-fluoroacetate PET/CT as a tumor-imaging modality: preclinical study in healthy volunteers and clinical evaluation in patients with liver tumor.
    Takemoto K; Hatano E; Nishii R; Kagawa S; Kishibe Y; Takahashi M; Yamauchi H; Matsumura K; Zaima M; Toriguchi K; Tanabe K; Kitamura K; Seo S; Taura K; Endo K; Uemoto S; Higashi T
    Ann Nucl Med; 2014 May; 28(4):371-80. PubMed ID: 24599824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis.
    Padia SA; Alessio A; Kwan SW; Lewis DH; Vaidya S; Minoshima S
    J Vasc Interv Radiol; 2013 Aug; 24(8):1147-53. PubMed ID: 23792126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of 18-fluorodeoxyglucose positron emission tomography in the evaluation of tumor cardiac thrombus from renal cell carcinoma.
    García JR; Simo M; Huguet M; Ysamat M; Lomeña F
    Clin Transl Oncol; 2006 Feb; 8(2):124-8. PubMed ID: 16632427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography imaging of renal vein and inferior vena cava tumor thrombus from renal cell carcinoma.
    Nguyen BD
    Clin Nucl Med; 2005 Feb; 30(2):107-9. PubMed ID: 15647678
    [No Abstract]   [Full Text] [Related]  

  • 17. FDG uptake in inferior vena cava tumor thrombus from renal cell carcinoma on positron emission tomography.
    Sizemore AW; Jacobs MP; Mantil JC; Hahm GK
    Clin Nucl Med; 2007 Apr; 32(4):309-11. PubMed ID: 17413583
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic Value of FDG Uptake of Portal Vein Tumor Thrombosis in Patients With Locally Advanced Hepatocellular Carcinoma.
    Lee JW; Hwang SH; Kim DY; Han KH; Yun M
    Clin Nucl Med; 2017 Jan; 42(1):e35-e40. PubMed ID: 27775940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
    Ho CL; Chen S; Yeung DW; Cheng TK
    J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of 18F fluoro-2-désoxy-D-glucose positron emission tomography/computed tomography for the diagnosis of venous thromboembolism.
    Le Roux PY; Robin P; Delluc A; Tardy B; Abgral R; Couturaud F; Reffad A; Le Gal G; Salaun PY
    Thromb Res; 2015 Jan; 135(1):31-5. PubMed ID: 25455997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.